To investigate the role of Six1 in pancreatic cancer development, we tested the expression of Six1 in 51 pancreatic ductal adenocarcinomas and 13 adjacent non-tumor pancreatic tissue samples using quantitative Real-time RT-PCR. Here, SIX1 is linked to neoplasm.